Post-thrombotic Syndrome: Clinical Trials

3 trials for Post-thrombotic Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown, 1 withdrawn. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Post-thrombotic Syndrome: new trials by email Literature Review of Post-thrombotic Syndrome trials Research Report on Post-thrombotic Syndrome

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Design and Rationale of the COLT Study
Colchicine 0.5 MG Oral Tablet, Placebo - Venous Thrombosis Deep (Limbs), Post-thrombotic Syndrome
Phase 3Not yet recruitingAzienda Sanitaria Locale ASL 6, Livorno9402026-06-012026-02-25
The MUFFIN-PTS Trial
Micronized Purified Flavonoid Fraction, Placebo - Post-Thrombotic Syndrome
Phase 3UnknownSir Mortimer B. Davis - Jewish General Hospital882022-02-042023-11-30
Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Recombinant tissue plasminogen activator (rt-PA), Standard Anticoagulation Therapy - Deep Vein Thrombosis, Post-Thrombotic Syndrome
Phase 3WithdrawnUniversity of Colorado, Denver2018-07-012018-08-10

Narrower conditions

Postthrombotic Syndrome (3)  ·  Venous Thrombosis (3)  ·  Inflammation (1)  ·  Thrombosis (1)  ·  Venous Insufficiency (1)  ·  Venous Thromboembolism (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Embolism and Thrombosis (3)  ·  Vascular Diseases (3)  ·  Thrombosis (2)  ·  Venous Insufficiency (2)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Thromboembolism (1)

Interventions

Colchicine (1)  ·  Tablets (1)  ·  Tissue Plasminogen Activator (1)

Sponsors

Azienda Sanitaria Locale ASL 6, Livorno (1)  ·  Sir Mortimer B. Davis - Jewish General Hospital (1)  ·  University of Colorado, Denver (1)

Countries

Canada (1)

Top investigators

Jean-Philippe Galanaud, MD, PhD (1)  ·  Marilyn J Manco-Johnson, MD (1)  ·  Susan R Kahn, MD, MSc (1)

Results publications

PMID 34518263